mechanism

Synucleinopathies

Entity Detail — Knowledge Graph Node

Understanding Entity Pages

This page aggregates everything SciDEX knows about Synucleinopathies: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.

23Connections
0Hypotheses
1Analyses
1Outgoing
22Incoming
0Experiments
1Debates

Summary

Synucleinopathies are a group of neurodegenerative disorders characterized by the abnormal accumulation of alpha-synuclein (α-syn) protein within neurons, glial cells, and extracellular spaces[@spillantini1997]. This class of diseases includes Parkinson's disease (PD), dementia with Lewy bodies (DLB

View on Wiki →

No AI portrait yet

Mechanism Info
NameSynucleinopathies
Key Genes/ProteinsAlpha-Synuclein, ALPHA-SYNUCLEIN, DNAJB6, GCASE, SNCA, α-Synuclein Aggregates
Related PathwaysFibril Polymorphs

Wiki Pages (5)

Knowledge base pages for this entity

Canonical Page

Synucleinopathies

mechanism · 4112 words

SNCA→Alpha-synuclein→Aggregation→Lewy Bodies→Synucleinopathies Causal Chain

pathway · 3707 words

REM Sleep Behavior Disorder (RBD) - Diagnostic Marker for Synucleinopathies

diagnostic · 1866 words

[18F]ACI-15916 PET Alpha-Synucleinopathies Imaging Trial

clinical_trial · 972 words

Alpha-Synucleinopathies Comparison Matrix

disease · 853 words

Pathway Diagram

flowchart TD
    Synucleinopathies{{"Synucleinopathies"}}
    Alpha_Synuclein(["Alpha-Synuclein"])
    Alpha_Synuclein -->|"causes"| Synucleinopathies
    ALPHA_SYNUCLEIN(["ALPHA-SYNUCLEIN"])
    ALPHA_SYNUCLEIN -->|"causes"| Synucleinopathies
    SNCA(["SNCA"])
    SNCA -->|"involved in"| Synucleinopathies
    SNCA -->|"causes"| Synucleinopathies
    Synucleinopathies -->|"associated with"| SNCA
    __Synuclein_Aggregates("alpha-Synuclein Aggregates")
    __Synuclein_Aggregates -->|"biomarker for"| Synucleinopathies
    SNCA -->|"biomarker for"| Synucleinopathies
    __Synuclein_Aggregates -->|"causes"| Synucleinopathies
    SNCA -->|"associated with"| Synucleinopathies
    GCASE("GCASE")
    GCASE -->|"risk factor for"| Synucleinopathies
    DNAJB6(["DNAJB6"])
    DNAJB6 -->|"protects against"| Synucleinopathies

    style Synucleinopathies fill:#4a148c,stroke:#4fc3f7,stroke-width:3px,color:#fff

Outgoing (1)

TargetRelationTypeStr
SNCAassociated_withprotein0.90

Incoming (22)

SourceRelationTypeStr
entities-glymphatic-systeminvolved_inwiki0.00
Alpha-Synucleincausesprotein0.95
SNCAassociated_withgene0.95
ALPHA-SYNUCLEINcausesprotein0.95
SNCAcausesprotein0.95

Targeting Hypotheses (0)

Hypotheses where this entity is a therapeutic target

HypothesisScoreDiseaseAnalysis
No targeting hypotheses

Mentioning Analyses (1)

Scientific analyses that reference this entity

How does PSEN2 mechanistically regulate α-synuclein expression and pathology in

neurodegeneration | 2026-04-13 | 0 hypotheses

Experiments (0)

Experimental studies targeting or related to this entity

ExperimentTypeDiseaseScoreFeasibilityModelStatusEst. Cost
No experiments found

Related Papers (0)

Scientific publications cited in analyses involving this entity

Title & PMIDAuthorsJournalYearCitations
No papers found

Debates (1)

Multi-agent debates referencing this entity

The study shows PSEN2 is essential in cortical and dopaminergic neurons and regu

closed · Rounds: 4 · Score: 0.68 · 2026-04-16

Related Research

Hypotheses and analyses mentioning Synucleinopathies in their description or question text

No additional research found